EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of 161Tb-Labeled Diphosphonates as Potential Bone-Targeting Agents

Pavle Sitarica iD, Aleksandar Vukadinović iD, Miloš Marić iD, Sanja Vranješ-Đurić, Dalibor Stanković iD, Marko Perić, Drina Janković iD, Dragana Stanković iD, Marija Mirković iD, Magdalena Radović iD

International Journal of Molecular Sciences · 25.10.2025 · 26 (21) · 10392

DOI: 10.3390/ijms262110392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.10.2025. Verfasst von Pavle Sitarica und 9 weiteren Autor:innen. Beteiligte Einrichtung: "VINČA" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia. Hauptthemen laut MEDLINE: Diphosphonates, Bone and Bones, Radiopharmaceuticals. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development, and Innovation of the Republic of Serbia, Science Fund of the Republic of Serbia, bilateral Serbia-NR China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Two diphosphonates, etidronic acid (HEDP) and zoledronic acid (ZOL), were radiolabelled with 161Tb and evaluated as potential bone-targeting radiopharmaceuticals. Radiolabeling was performed at pH 7, achieving high radiolabeling yields (greater than 98%) and demonstrating excellent in vitro stability in saline and human serum. Both radiolabeled complexes exhibited hydrophilic behavior, a strong binding affinity to hydroxyapatite, and moderate to high plasma protein binding. Biodistribution studies in healthy Wistar rats demonstrated that 161Tb-HEDP and 161Tb-ZOL achieve high and stable skeletal uptake with rapid blood clearance and minimal soft tissue accumulation. 161Tb-HEDP favored higher initial bone localization, while 161Tb-ZOL showed lower renal and hepatic accumulation, indicating higher safety and selectivity. Compared to unchelated 161TbCl3, both diphosphonate complexes exhibited significantly higher bone-to-kidney and bone-to-liver ratios, resulting in superior targeting. Complementary experiments with non-radioactive terbium were performed to investigate the redox behavior and confirm complex formation, providing valuable insight into the stability and binding modes of the ligands. Both terbium and the ligands displayed well-defined redox behavior within the potential range of −1 to 1.7 V, with complex formation evidenced by shifts in the oxidation peaks. Density functional theory (DFT) calculations further supported these findings, showing that both phosphonate groups of a ligand coordinate to Tb3+, while the hydroxyl groups in HEDP enable intermolecular hydrogen bonding, contributing to additional structural stabilization. Results encourage further investigations of 161Tb-labeled diphosphonates as promising candidates for radionuclide therapy of bone metastases and other skeletal diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DiphosphonatesBone and BonesRadiopharmaceuticalsAnimalsRatsTissue DistributionRats, WistarZoledronic AcidMaleHumansEtidronic Acid

Stichwörter der Autor:innen

161Tb-labeled diphosphonatesDFTHEDPZOLbiodistributionbone-targetingelectrochemical behaviorhydroxyapatite binding

Substanzen

DiphosphonatesRadiopharmaceuticalsZoledronic AcidEtidronic Acid

Autor:innen und Institutionen

  • "VINČA" Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, 11001 Belgrade, Serbia.
  • Faculty of Chemistry, University of Belgrade, 11001 Belgrade, Serbia.

ORCID-Profile: Pavle Sitarica, Aleksandar Vukadinović, Miloš Marić, Dalibor Stanković, Drina Janković, Dragana Stanković, Marija Mirković, Magdalena Radović

Förderung

  • Ministry of Science, Technological Development, and Innovation of the Republic of Serbia
  • Science Fund of the Republic of Serbia
  • bilateral Serbia-NR China

Zitieren

APA

Sitarica, P., Vukadinović, A., Marić, M., Vranješ-Đurić, S., Stanković, D., Perić, M., Janković, D., Stanković, D., Mirković, M., & Radović, M. (2025). Evaluation of 161Tb-Labeled Diphosphonates as Potential Bone-Targeting Agents. International Journal of Molecular Sciences, 26(21), 10392. https://doi.org/10.3390/ijms262110392

Vancouver

Sitarica P, Vukadinović A, Marić M, Vranješ-Đurić S, Stanković D, Perić M, et al. Evaluation of 161Tb-Labeled Diphosphonates as Potential Bone-Targeting Agents. International Journal of Molecular Sciences. 2025;26(21):10392. doi:10.3390/ijms262110392

BibTeX
@article{Sitarica2025,
  author = {Sitarica, Pavle and Vukadinović, Aleksandar and Marić, Miloš and Vranješ-Đurić, Sanja and Stanković, Dalibor and Perić, Marko and Janković, Drina and Stanković, Dragana and Mirković, Marija and Radović, Magdalena},
  title = {Evaluation of 161Tb-Labeled Diphosphonates as Potential Bone-Targeting Agents},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {21},
  pages = {10392},
  doi = {10.3390/ijms262110392}
}
Kostenlos starten →